NMSU Alumnus & Former MARC Program Participant Featured in Forbes 30 Under 30 Healthcare 2020

416x416-300x300.jpgDr. Bobby Brooke Herrera was just announced as one of the     Forbes 30 Under 30 Healthcare honorees for 2020. Forbes recognizes the top 30 scientists who are under 30 years of age for their contributions in the healthcare arena. Dr. Herrera is the cofounder of E25Bio, a company that is developing rapid, low-cost diagnostic test kits for those living in developing countries. He received his bachelors degree in biology in 2012 with a minor in chemistry. While at NMSU he participated in the Maximizing Access to Research Careers (MARC) program where he worked with Prof. Maria Castillo. After leaving NMSU, he completed a doctorate (in 2018) in biomedical research from the Harvard Graduate school where he focused on the development of T-cell based diagnostic tools for the Zika and Ebola viruses.







New Mexico State University Assistant Professor Dr. Kevin Houston has been awarded $1 million by the NIH


New Mexico INBRE investigator Dr. Kevin Houston has been awarded a $1 million, four-year grant from the National Institutes of Health (NIH) to investigate how GPER1-dependent mechanisms of tamoxifen action contribute to tamoxifen resistance in breast cancer cells. 
The goal of this multiyear study entitled “GPER1-Dependent Regulation of IGF-1R in Tamoxifen Treated Breast Cancer Cells” is to further characterize how GPER1 is involved in the development of tamoxifen resistance in breast cancer cells and to identify potential targets for future design of pharmaceutical treatments that can lessen the likelihood that resistance will develop in breast cancer patients that are treated with tamoxifen.
In addition, this funding will provide the resources necessary to encourage and support both undergraduate and graduate students in research training while they are completing their studies at NMSU.